- VISION
- Discovering and developing innovative medicines to conquer chronic or life-threatening diseases with high unmet needs
- MISSION
- Drugging the undruggable targets with small molecules and new chemical modalities
- Cyrus Therapeutics is a leading biotechnology company that is discovering and developing innovative medicines to conquer chronic or life-threatening diseases with high unmet needs. It is estimated that about 3,000 targets are ‘undruggable’ (about 16% of a total of 20,000 human proteins). We are committed to making our mission—‘drugging the undruggable targets’—possible with small molecule drugs as well as new chemical modalities such as targeted protein degraders.
LEADERSHIP
OUR PARTNERS
To make our drug discovery faster and more effective, we are collaborating with top-tier drug discovery companies, research institutes, and universities including St. Jude Children’s Research Hospital, GC Biopharma, Kanaph Therapeutics, Bridge Biotherapeutics, YONSEI CANCER CENTER, and College of Pharmacy, SNU
- Ph.D. / CEO, Founder
- Byong-Moon Kim
- Executive Senior Vice President, Head of R&D/Global Business, CJ HealthCare
- Executive Senior Vice President, Head of Biomed Strategy Division, CJ CheilJedang
- Senior Vice President, Head of The Research Institute, Dong-A ST/Dong-A Socio Holdings
- Director, Board of Directors, Institute Pasteur Korea
- Visiting Scientist, The Catholic University of America in Washington, D.C., USA
- Visiting Scientist, NIAAA, National Institutes of Health in Maryland, USA
- B.S./M.S./Ph.D. in Biotechnology, Korea University
- RPh / CBO
- Seong Jin KIM
- CBO, CJ HealthCare Inc.
- CBO, CJ CheilJedang Inc.
- Head of Development, TaeJoon Pharm
- Team leader, LG LifeSciences(BD, RA, Clinical, Strategic Planning)
- B.S. in Pharmacy, Chungang University
- Ph.D. / CSO
- Wooseok Han
- Principal Scientist, Novartis Institutes for BioMedical Research
- Scientist, Chiron Corporation
- Post-doc. Fellow, The Scripps Research Institute
- Ph.D. in Organic Chemistry, University of Toronto
- M.S. in Organic Chemistry, KAIST
- B.S. in Chemistry, Yonsei University
- Ph.D. / Head of CMC
- Seogbeom Song
- Head of New drug development center, CJ Healthcare
- Head of Drug Analysis Center, CJ Healthcare
- Ph.D. in Chemistry, KAIST
- B.S./M.S. in Chemistry, Korea University
- Ph.D. / Scientific Director of Cancer Biology
- Dong Hyuk Ki
- Instructor, Dana-Farber Cancer Institute/Harvard Medical School
- Post-Doc Fellow, Dana-Farber Cancer Institute/Harvard Medical School
- Ph.D. in Molecular and Cellular Biology, Stony Brook University
- M.S. in Biomedical Science, Yonsei University
- B.S. in Life Science, Yonsei University
- Ph.D. / Head of Medicinal Chemistry
- Joonwoo Nam
- CSO, Onconic Therapeutics Inc.
- Director of Medicinal Chemistry, Jeil Pharmaceutical Co., Ltd.
- Principal Research Scientist, CrystalGenomics Inc.
- Research Scientist, CytRx Corporation
- Post-doc. Fellow, The Scripps Research Institute
- Ph.D. in Organic Chemistry, Princeton University
- M.S./B.S. in Chemistry, Yonsei University
- Executive Director / CMO
- Sol Han
- VP / Head of Clinical Development, Novelty Nobility Inc.
- AP-EMEA region - The first Regional Study Manager from Asia, Sanofi
- Project, CTA regulatory & Operational excellence manager, Sanofi
- Project leader, GlaxoSmithKline
- Snr. site manager, Roche
- Site manager, Otsuka Pharmaceutical
- M.S/B.S in Pharmacy, Ewha Womans University (licensed pharmacist)
- Ph.D. / Head of Pharmacology & Translational Research
- Eun-Jung Kim
- Senior Research Fellow, Dong-A ST/Dong-A Socio Holdings
- Ph.D. in Pharmacology, Seoul National University
- B.S./M.S. in Pharmacy, Seoul National University
- Executive Director / COO
- Cheol-Jun Bae
- Executive Director, Planning/BD, SCAI Therapeutics
- Team Leader of Business Development, Dong-A ST
- Team Leader of Research Planning, Dong-A Pharmaceutical
- Sungkyunkwan Univ. Ph.D. course work for industrial pharmacy
- M.S./B.S. in Pharmacy, Seoul National University
- Executive Director / CFO
- Yong Cheol Kang
- General Manager, Investment Banking Division (IPO, M&A, Fundraising), Mirae Asset Daewoo
- B.A. in Business Administration, Konkuk University
- Scientific Director of Cancer Biology / Ph.D.
- Heuijoon Park
- Post-Doctoral Research Fellow, Fred Hutchinson Cancer Research Center
- Postdoctoral Associate, The Rockefeller University
- Ph.D. in Pathology and Cell Biology, Columbia University Vagelos College of Physicians and Surgeons
- B.S. in Biology, Dankook University